Dexamethasone No Help in HIV-Linked Cryptococcal Meningitis

Share this content:
Dexamethasone No Help in HIV-Linked Cryptococcal Meningitis
Dexamethasone No Help in HIV-Linked Cryptococcal Meningitis

FRIDAY, Feb. 12, 2016 (HealthDay News) -- For patients with HIV-associated cryptococcal meningitis, dexamethasone does not reduce mortality compared with placebo, according to a study published in the Feb. 11 issue of the New England Journal of Medicine.

Justin Beardsley, M.B., Ch.B., from the Oxford University Clinical Research Unit in the United Kingdom, and colleagues recruited adult patients with HIV-associated cryptococcal meningitis in Vietnam, Thailand, Indonesia, Laos, Uganda, and Malawi. Participants were randomized to dexamethasone or placebo for six weeks, with combination antifungal therapy with amphotericin B and fluconazole.

After enrollment of 451 patients the trial was stopped for safety reasons. The researchers found that by 10 weeks, mortality was 47 and 41 percent in the dexamethasone and placebo groups, respectively (hazard ratio in the dexamethasone group, 1.11; 95 percent confidence interval, 0.84 to 1.47); by six months, mortality was 57 and 49 percent, respectively (hazard ratio, 1.18; 95 percent confidence interval, 0.91 to 1.53). At 10 weeks, the percentage of patients with disability was higher in the dexamethasone versus the placebo group (13 and 25 percent with a prespecified good outcome, respectively; odds ratio, 0.42; 95 percent confidence interval, 0.25 to 0.69). Compared with the placebo group, the dexamethasone group more frequently had clinical adverse events (667 versus 494 events; P = 0.01)

"Dexamethasone did not reduce mortality among patients with HIV-associated cryptococcal meningitis and was associated with more adverse events and disability than was placebo," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Meds for Opioid Use Disorder May Reduce Mortality in OD Survivors

Meds for Opioid Use Disorder May Reduce Mortality ...

Minority of opioid overdose survivors receive MOUD; buprenorphine, MMT linked to reduced mortality

Pharmacists Are Well Placed to Improve Adult Vaccination Rates

Pharmacists Are Well Placed to Improve Adult Vaccination ...

Pharmacies can address cost barriers to vaccination by providing vaccines at lower cost

Single Blood Sample Test May Help ID Undiagnosed Diabetes

Single Blood Sample Test May Help ID Undiagnosed ...

Single-sample confirmatory definition associated with high positive predictive value

is free, fast, and customized just for you!




Already a member?

Sign In Now »